BioMarin Pharmaceutical Inc. (BMRN) is in the Pharma Industry

• Sort by
• View by Content Type
• View Related Content by Tag

• Biotech Outlook: M&A Will Continue

  Zacks.com submits: Checking on the biotechnology sector, we spoke with Zacks senior analyst Grant Zeng, CFA about recent developments among these companies. We discussed M&A [mergers and acquisitions] activity as well as top Buy recommendations. How has earnings season gone this quarter? Any major surprises? by...

  External links 2008-09-02

  Tags: Biotech, Healthcare, AMAG Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., Bristol-Myers Squibb Co., Celgene Corp., Genentech Inc., ImClone Systems Inc., MannKind Corp., Trimeris Inc.

• BioMarin Pharmaceutical, Inc. Q2 2008 Earnings Call Transcript

  Question-and-Answer SessionThank you madam. [Operator Instructions]. And your first question comes from the line of Brian Abrahams [ph] with Oppenheimer. Please proceed. Unidentified Analyst Hi guys, Thanks for taking my questions Just a question on the Kuvan launch, you mentioned that... it sounds like a vast majority of the...

  Earnings calls 2008-08-05

  Tags: BioMarin Pharmaceutical Inc.

• BioMarin Pharmaceutical, Inc. Q1 2008 Earnings Call Transcript

  Question-and-Answer Session[Operator Instructions]. Your first question comes from the line of Chris Raymond from Robert Baird. Please proceed. Christopher Raymond - Robert W. Baird Thanks for taking my question. I just was wondering and I know it's very early in the launch with Kuvan but you know that 509...

  Earnings calls 2008-04-29

  Tags: BioMarin Pharmaceutical Inc.

• BioMarin Pharmaceutical, Inc. Q4 2007 Earnings Call Transcript

  Question-and-Answer Session[Operator Instructions]. And your first question comes from the line of Salveen Kochnover of Jefferies. Please proceed. Salveen Kochnover - Jefferies & Company Hi, thank you for taking my questions. Jeff, could you provide us with some expense line guidance for '08? Jeffrey H. Cooper - Vice President...

  Earnings calls 2008-03-04

  Tags: BioMarin Pharmaceutical Inc.

Additional Resources

• BioMarin to Host Third Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, October 28 at 5:00 p.m. ET

  NOVATO, Calif., Oct. 7 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 28, at 5:00 p.m. ET (23:00 CET) to discuss third quarter 2008 financial results. U.S. / Canada...

  Articles 2008-10-07

• BioMarin Opens Office in Brisbane to Support Expanding Operations

  NOVATO, Calif, Oct. 7 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. announced today that it has opened a new office in Brisbane, California, to expand its drug development operations and better meet the increasing demands of the company's growing product pipeline. The company will occupy approximately 20,000 square feet of...

  Articles 2008-10-07

• Kuvan Receives Positive Opinion From CHMP for European Approval

  Decision on Marketing Authorization Expected by End of 2008 NOVATO, Calif., Sept. 25 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. announced today that its partner Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has received a positive opinion for KuvanR sapropterin dihydrochloride as an oral treatment for...

  Articles 2008-09-25

• BioMarin Corrects Information Included in Bloomberg Article

  NOVATO, Calif., Sept. 18 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. announced today several corrections to an article released by Bloomberg this morning. The article was based on a telephone interview with Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, held on September 17, 2008. Following is the...

  Articles 2008-09-18

• BioMarin Announces Roll-Out of National PKU Registry

  Conference Call and Webcast to Be Held Today at 4:30 p.m. ET (21:30 CET) NOVATO, Calif., Aug. 21 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. announced today the roll-out of the national PKU Demographics, Outcomes and Safety Registry PKUDOS. The registry is open to all PKU clinics...

  Articles 2008-08-21

• BellwetherReport.com Analyst Report on QSFT, LAMR, BMRN and PCLN

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...

  Articles 2008-08-06

• Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer

  Pipex Pharmaceuticals, Inc. (AMEX: PP), aspecialty pharmaceutical company developing innovative late-stage drugcandidates for the treatment of central nervous system and autoimmunediseases, announced today that Nicholas Stergis, co-founder of the Companyand Vice Chairman of the board of directors, has joined the executivemanagement team of Pipex as Chief Executive Officer,...

  Articles 2008-07-08

• BellwetherReport.com Analyst Report on INTC, EBAY, IVGN and BMRN

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews...

  Articles 2008-06-12

• BioMarin to Present at the Bank of America Healthcare Conference

  NOVATO, Calif., May 7 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the Bank of America Healthcare Conference in Las Vegas on Wednesday, May 14, 2008 at 1:20 p.m. PT. ...

  Articles 2008-05-07

• BioMarin to Present at the Baird Growth Stock Conference

  NOVATO, Calif, May 6 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that Stephen Aselage, Senior Vice President of Global Commercial Development of BioMarin, will present a company update at the Baird Growth Stock Conference in Chicago on Tuesday, May 13, 2008 at 7:45 a.m. CT....

  Articles 2008-05-06

• BellwetherReport.com Initiates Analyst Coverage on BMRN, ARRS, SVVS and FSLR

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have scheduled interviews with a number of...

  Articles 2008-04-30

• Zacks Analyst Interview Highlights: Regeneron Pharmaceuticals, ZymoGenetics, Eurand N.V., Myriad Genetics and BioMarin Pharmaceuticals

  CHICAGO -- Zacks.com releases the latest Analyst Interview. Today's interview is with senior analyst Grant Zeng, who discusses Regeneron Pharmaceuticals (Nasdaq: REGN), ZymoGenetics Inc. (Nasdaq: ZGEN), Eurand N.V. (Nasdaq: EURX), Myriad Genetics (Nasdaq: MYGN) and BioMarin Pharmaceuticals (Nasdaq: BMRN). A synopsis of today's Analyst Interview is presented below....

  Articles 2008-04-22

• AnGes MG, Inc. Launches Naglazyme in Japan

  Tokyo, Japan, Apr 15, 2008 - JCN Newswire - AnGes MG, Inc. (TSE: 4563) announced that on April 14 that the company launched Naglazyme galsulfase for patients with the genetic disease mucopolysaccharidosis VI (MPS VI; Maroteaux-Lamy syndrome). Naglazyme is the first product commercialized by AnGes. AnGes established a...

  Articles 2008-04-15

• BioMarin to Present at the Lehman Brothers Global Healthcare Conference

  NOVATO, Calif., March 12 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the Lehman Brothers Global Healthcare Conference in Miami on Wednesday, March 19, 2008 at 2:00 p.m. ET. Interested...

  Articles 2008-03-12

• BioMarin Pharmaceutical Inc. To Present at Cowen & Company 28th Annual Health Care Conference on March 18, 2008.

  M2 PRESSWIRE-12 March 2008-investorIM: BioMarin Pharmaceutical Inc. To Present at Cowen & Company 28th Annual Health Care Conference on March 18, 2008C1994-2008 M2 COMMUNICATIONS LTD RDATE:12032008 InvestorIM has been created as a tool for the average investor. The idea...

  Articles 2008-03-12

• Has added BioMarin Pharmaceuticals Inc. to their watch list.

  M2 PRESSWIRE-12 March 2008-The Maybach Financial Group: Has added BioMarin Pharmaceuticals Inc. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:12032008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants,...

  Articles 2008-03-12